SCOTT L LUNDAHL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SCOTT L LUNDAHL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT L LUNDAHL. SCOTT L LUNDAHL is Vice President, Technology in DUSA PHARMACEUTICALS INC ($DUSA) and VP, Regulatory Affairs & IP in DUSA PHARMACEUTICALS INC ($DUSA).
Latest Insider Trading Transactions of SCOTT L LUNDAHL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 1.65 | 55,000 | 90,750 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 1.22 | 54,600 | 66,612 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 2.20 | 16,500 | 36,300 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 6.75 | 15,000 | 101,250 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 10.00 | 20,000 | 200,000 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | D | 9.92 | 22,500 | 223,200 | 0 | |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | U | 8.00 | 149,200 | 1,193,600 | 0 | 149.2 K to 0 (-100.00 %) |
| Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | U | 8.00 | 61,014 | 488,112 | 0 | 61 K to 0 (-100.00 %) |
| May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 6.13 | 872 | 5,345 | 210,214 | 211.1 K to 210.2 K (-0.41 %) |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | M | 1.60 | 17,500 | 28,000 | 0 | |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.84 | 1,600 | 9,344 | 211,086 | 212.7 K to 211.1 K (-0.75 %) |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.81 | 800 | 4,648 | 212,686 | 213.5 K to 212.7 K (-0.37 %) |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.80 | 5,224 | 30,299 | 213,486 | 218.7 K to 213.5 K (-2.39 %) |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.76 | 1,900 | 10,944 | 218,710 | 220.6 K to 218.7 K (-0.86 %) |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.75 | 7,976 | 45,862 | 220,610 | 228.6 K to 220.6 K (-3.49 %) |
| Mar 19 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Buy | M | 1.60 | 17,500 | 28,000 | 228,586 | 211.1 K to 228.6 K (+8.29 %) |
| Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 5.86 | 2,203 | 12,910 | 211,086 | 213.3 K to 211.1 K (-1.03 %) |
| Mar 09 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Grant | A | 0.00 | 95,000 | 0 | 213,289 | 118.3 K to 213.3 K (+80.31 %) |
| Mar 09 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 6.05 | 3,566 | 21,574 | 118,289 | 121.9 K to 118.3 K (-2.93 %) |
| Mar 07 2012 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 4.65 | 2,140 | 9,951 | 121,855 | 124 K to 121.9 K (-1.73 %) |
| May 17 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | M | 1.22 | 10,000 | 12,200 | 0 | |
| May 17 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | M | 3.87 | 17,500 | 67,725 | 0 | |
| May 17 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.96 | 1,000 | 5,960 | 123,995 | 125 K to 124 K (-0.80 %) |
| May 17 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Buy | M | 1.22 | 1,000 | 1,220 | 124,995 | 124 K to 125 K (+0.81 %) |
| May 17 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Sell | S | 5.95 | 17,500 | 104,125 | 123,995 | 141.5 K to 124 K (-12.37 %) |
| May 17 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Buy | M | 3.87 | 17,500 | 67,725 | 141,495 | 124 K to 141.5 K (+14.11 %) |
| May 11 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 5.80 | 873 | 5,063 | 123,995 | 124.9 K to 124 K (-0.70 %) |
| Mar 14 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 4.15 | 2,207 | 9,159 | 124,868 | 127.1 K to 124.9 K (-1.74 %) |
| Mar 08 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Grant | A | 0.00 | 45,000 | 0 | 125,075 | 80.1 K to 125.1 K (+56.20 %) |
| Mar 08 2011 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 3.95 | 2,143 | 8,465 | 80,075 | 82.2 K to 80.1 K (-2.61 %) |
| May 10 2010 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 2.01 | 873 | 1,755 | 84,218 | 85.1 K to 84.2 K (-1.03 %) |
| Mar 16 2010 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Payment of Exercise | F | 1.78 | 2,638 | 4,696 | 85,091 | 87.7 K to 85.1 K (-3.01 %) |
| Mar 08 2010 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | A | 1.65 | 55,000 | 90,750 | 55,000 | |
| Mar 08 2010 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Grant | A | 0.00 | 27,000 | 0 | 87,729 | 60.7 K to 87.7 K (+44.46 %) |
| Dec 18 2009 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Buy | P | 1.31 | 5,322 | 6,972 | 60,729 | 55.4 K to 60.7 K (+9.61 %) |
| Dec 18 2009 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Buy | P | 1.34 | 11,400 | 15,276 | 55,407 | 44 K to 55.4 K (+25.90 %) |
| Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | A | 1.22 | 55,600 | 67,832 | 55,600 | |
| Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Grant | A | 0.00 | 27,800 | 0 | 44,007 | 16.2 K to 44 K (+171.53 %) |
| May 12 2008 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | A | 2.20 | 16,500 | 36,300 | 16,500 | |
| May 12 2008 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
| Mar 21 2007 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | A | 3.37 | 20,000 | 67,400 | 215,000 | |
| Mar 29 2006 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | A | 6.75 | 15,000 | 101,250 | 15,000 | |
| Mar 21 2005 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | VP, Regulatory Affa ... | Option Exercise | A | 10.00 | 20,000 | 200,000 | 20,000 | |
| Mar 22 2004 | DUSA | DUSA PHARMACEUTICA ... | LUNDAHL SCOTT L | Vice President, Tec ... | Option Exercise | A | 9.92 | 22,500 | 223,200 | 22,500 |
Page: 1